Published in Thromb Haemost on February 01, 1999
Recombinant activated factor VII in post partum haemorrhage. Niger Med J (2013) 0.75
Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum (1995) 2.48
Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr (1996) 1.80
Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). Thromb Haemost (2002) 1.56
Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children. Br Heart J (1993) 1.43
Relationship between thrombin generation and carotid intima-media thickness. Hamostaseologie (2010) 1.40
A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity. Blood (1982) 1.12
Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb Haemost (2002) 1.05
Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia. Pediatrics (1995) 1.01
Longer aPTT values in healthy children than in adults: no single cause. Thromb Res (1997) 0.97
Lupus anticoagulant and factor XII activity in children with prolonged PTT. Thromb Res (1996) 0.97
Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates. J Thromb Haemost (2003) 0.96
[Loss of inhibitors of the blood coagulation system in protein-losing enteropathy (author's transl)]. Klin Padiatr (1979) 0.92
Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost (1998) 0.90
The role of inherited thrombotic disorders in the etiology of Legg-Calvé-Perthes disease. J Pediatr Orthop (1999) 0.90
Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma. J Thromb Haemost (2003) 0.88
Influence of high molecular weight factor VIII on the measurement of low molecular weight factor VIII procoagulant in different assay systems. Br J Haematol (1982) 0.87
Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin. Thromb Haemost (1997) 0.86
Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates. Blood (1988) 0.85
Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA. Blood Coagul Fibrinolysis (2002) 0.84
Haemostatic alterations in overweight children: associations between metabolic syndrome, thrombin generation, and fibrinogen levels. Atherosclerosis (2010) 0.84
Thrombin generation in severely obese children. J Thromb Haemost (2006) 0.83
Heparin inhibition of the cytostatic effect of Adriamycin on cultured lymphocytes. Acta Haematol (1981) 0.82
Danaparoid sodium (Orgaran) in four children with heparin-induced thrombocytopenia type II. Acta Paediatr (2001) 0.82
Treatment of children with haemophilia in Europe: a survey of 20 centres in 16 countries. Haemophilia (2000) 0.81
Haemostatic changes in tall girls treated with high doses of ethinyloestradiol. Eur J Pediatr (1980) 0.81
Flow cytometric detection of intracellular platelet antigens. Cytometry (1996) 0.81
Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord (2000) 0.81
Thrombin generation in factor VIII-depleted neonatal plasma: nearly normal because of physiologically low antithrombin and tissue factor pathway inhibitor. J Thromb Haemost (2006) 0.81
Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord (2001) 0.80
Plasma concentrations after intravenous administration of phylloquinone (vitamin K(1)) in preterm and sick neonates. Thromb Res (2000) 0.80
Malignant stroke in an adolescent with a homozygous MTHFR 677CT mutation and intake of hormonal contraceptives. Hamostaseologie (2009) 0.80
Hyporeactivity of neonatal platelets is not caused by preactivation during birth. Eur J Pediatr (1997) 0.80
Shorter PFA-100 closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor. Acta Paediatr (2001) 0.79
Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity. Thromb Res (1998) 0.79
Effect of heparin, platelets, activated platelets, platelet fragments, and hematocrit on activated clotting time. Artif Organs (2000) 0.79
Method for the determination of vitamin K1(20) in human plasma by stable isotope dilution/gas chromatography/mass spectrometry. J Mass Spectrom (1996) 0.78
Normalization of haemostatic alterations in overweight children with weight loss due to lifestyle intervention. Atherosclerosis (2011) 0.78
Screening for haemorrhagic disorders in paediatric patients by means of a questionnaire. Hamostaseologie (2009) 0.78
More on: mild hemophilia A and inhibitor development. J Thromb Haemost (2004) 0.78
High titre inhibitor after continuous factor VIII administration for surgery in a young infant. Haemophilia (2000) 0.77
Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets (2010) 0.77
Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children. Klin Padiatr (2010) 0.77
No differences in support of thrombin generation by neonatal or adult platelets. Hamostaseologie (2009) 0.77
Regular smoking is not associated with increased thrombin generation in young adults. J Thromb Haemost (2013) 0.77
Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation. Int J Artif Organs (1997) 0.77
Comparative evaluation of PAR1, GPIb-IX-V, and integrin αIIbβ3 levels in cord and adult platelets. Hamostaseologie (2010) 0.76
Giant platelets in erucic acid therapy for adrenoleukodystrophy. Lancet (1993) 0.76
The influence of weight loss on fibrinolytic and metabolic parameters in obese children and adolescents. J Pediatr Endocrinol Metab (2001) 0.76
[Fetal alcohol syndrome and malignant tumors]. Wien Klin Wochenschr (1982) 0.76
Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism (2000) 0.76
Portal vein thrombosis in a 17-year-old female adolescent with essential thrombocytosis. Pediatr Hematol Oncol (1997) 0.76
A novel type of mutation at the propeptide cleavage site (AlA+1Thr) causing symptomatic protein C type II deficiency. Thromb Res (2000) 0.76
Demonstration of Epstein-Barr virus DNA in a previously healthy boy with fulminant hepatic failure. Eur J Pediatr (1986) 0.76
In vivo thrombin generation in neonates. J Thromb Haemost (2004) 0.75
Cutaneous necrosis associated with acquired severe protein S deficiency. Thromb Haemost (1994) 0.75
Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagul Fibrinolysis (2000) 0.75
Antiphospholipid antibodies in children. Thromb Res (2001) 0.75
Calibrated automated thrombin generation in paediatric patients with inflammatory bowel disease. Hamostaseologie (2009) 0.75
Effects of the glycoprotein IIb/IIIa receptor antagonist c7E3 Fab and anticoagulants on platelet aggregation and thrombin potential under high coagulant challenge in vitro. Blood Coagul Fibrinolysis (2000) 0.75
New therapies for severe meningococcal disease. Lancet (1998) 0.75
Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma. Wien Klin Wochenschr (1984) 0.75
Thrombin generation in paediatric patients with congenital heart disease. Determination by calibrated automated thrombography. Hamostaseologie (2008) 0.75
[Haemostasis in premature and newborn babies (author's transl)]. Padiatr Padol (1980) 0.75
Effects of growth hormone on the factor VIII complex in patients with growth hormone deficiency. Metabolism (1984) 0.75
Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma. Thromb Res (1999) 0.75
Hemorrhagic diathesis from transiently acquired Factor VIII complex deficiency. J Pediatr (1981) 0.75
[Make your own diagnosis]. Padiatr Padol (1979) 0.75
Fetal alcohol syndrome and malignant disease. Eur J Pediatr (1984) 0.75
Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids. Eur J Clin Invest (1984) 0.75
[What is your diagnosis? Transient erythroblastopenia of childhood]. Padiatr Padol (1982) 0.75
Arthralgia and digital clubbing in a child: hypertrophic osteoarthropathy with inflammatory pseudotumour of the lung. Scand J Rheumatol (2004) 0.75
[Coagulation tests from capillary blood. Determination of thromboplastin time, thrombin time, fibrinogen, factor II (prothrombin), factor V (accelerin) and factor X (Stuart-Prower factor) from capillary blood]. Z Kinderheilkd (1975) 0.75
[Pseudo-Perthes' disease caused by acute lymphatic leukemia]. Padiatr Padol (1983) 0.75
[Vitamin K deficiency in the newborn]. Wien Klin Wochenschr (1983) 0.75
[Pernio as cause of a blue toe syndrome]. Klin Padiatr (2006) 0.75
[What is your diagnosis? (Primary familial renal glycosuria)]. Padiatr Padol (1980) 0.75
[You make the diagnosis: hypohidrotic ectodermal dysplasia]. Padiatr Padol (1983) 0.75
Hemorrhagic complications of L-asparaginase therapy. J Pediatr (1983) 0.75
Immunologic studies of prothrombin in newborns. Pediatr Res (1979) 0.75
[Ketamine anesthesia for outpatient procedures in children (author's transl)]. Monatsschr Kinderheilkd (1980) 0.75
[Thrombasthenia in a newborn (author's transl)]. Padiatr Padol (1979) 0.75
Lupus anticoagulant after measles. Eur J Pediatr (1980) 0.75
Alpha-2-macroglobulin inhibits the anticoagulant action of activated protein C in cord and adult plasma. Haemostasis (2001) 0.75
Gly-pro-arg-pro (GPRP) enhances free thrombin. Thromb Res (1995) 0.75
[Ultrasound diagnosis in pediatrics]. Wien Klin Wochenschr (1985) 0.75
[Change of plasmatic blood coagulation factors by exchange transfusion using heparin and ACD blood in newborn infants]. Monatsschr Kinderheilkd (1979) 0.75
Effects of alpha(2)-macroglobulin and antithrombin on thrombin generation and inhibition in cord and adult plasma. Thromb Res (2001) 0.75
[What is your diagnosis?]. Padiatr Padol (1980) 0.75
[Biphasic splenic rupture in a hemophilic child (author's transl)]. Padiatr Padol (1981) 0.75
Enhanced thrombin generation in plasma of severe thrombocytopenic patients due to rFVIIa. Hamostaseologie (2008) 0.75
Reye's syndrome. Am J Dis Child (1980) 0.75
[Make your own diagnosis]. Padiatr Padol (1978) 0.75
[Intracranial hemorrhage in idiopathic thrombocytopenic purpura (ITP) (author's transl)]. Klin Padiatr (1976) 0.75
[Thrombocytopenia and IgA deficiency]. Padiatr Padol (1984) 0.75
Prothrombin fragment 1+2 during oral anticoagulation in congenital nephrotic syndrome. Pediatr Nephrol (1998) 0.75
Inverse correlation between thyroid function and hemostatic markers for coronary heart disease in obese children and adolescents. J Pediatr Endocrinol Metab (2001) 0.75